Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiotis Theofilis

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
World Journal of Radiology|July 10, 2024
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury preventionPanagiotis Theofilis, Rigas Kalaitzidis
World Journal of Gastroenterology|November 7, 2022
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerationsPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Metabolites|December 23, 2022
Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Life (Basel, Switzerland)|October 27, 2022
Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and MelatoninPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
American Journal of Nephrology|May 26, 2023
Epidemiology, Pathophysiology, and Clinical Perspectives of Intradialytic HypertensionPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Current Vascular Pharmacology|May 16, 2022
COVID-19 and Kidney Disease: A Clinical PerspectivePanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
American Journal of Nephrology|June 29, 2022
The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?Panagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Metabolites|November 10, 2022
Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017-2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic ScoresPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
World Journal of Cardiology|November 27, 2024
SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threatPanayotis K Vlachakis, Panagiotis Theofilis, Dimitris Tousoulis
Postgraduate Medicine|July 4, 2023
Novel therapeutic approaches in the management of chronic kidney disease: a narrative reviewPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
World Journal of Radiology|July 10, 2024
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury preventionPanagiotis Theofilis, Rigas Kalaitzidis
World Journal of Gastroenterology|November 7, 2022
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerationsPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Metabolites|December 23, 2022
Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Life (Basel, Switzerland)|October 27, 2022
Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and MelatoninPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
American Journal of Nephrology|May 26, 2023
Epidemiology, Pathophysiology, and Clinical Perspectives of Intradialytic HypertensionPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Current Vascular Pharmacology|May 16, 2022
COVID-19 and Kidney Disease: A Clinical PerspectivePanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
American Journal of Nephrology|June 29, 2022
The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?Panagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Metabolites|November 10, 2022
Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017-2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic ScoresPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
World Journal of Cardiology|November 27, 2024
SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threatPanayotis K Vlachakis, Panagiotis Theofilis, Dimitris Tousoulis
Postgraduate Medicine|July 4, 2023
Novel therapeutic approaches in the management of chronic kidney disease: a narrative reviewPanagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
Pageof 23